ENTRY       D12007                      Drug
NAME        Ubamatamab (USAN)
FORMULA     C6414H9917N1711O2016S44
EXACT_MASS  144574.3795
MOL_WEIGHT  144663.4849
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGRSLRL SCAASGFTFD DYSMHWVRQA PGKGLEWVSG ISWNSGSKGY
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TALYYCAKYG SGYGKFYHYG LDVWGQGTTV
            TVSSASTKGP SVFPLAPCSR STSESTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTKTYTCNVD HKPSNTKVDK RVESKYGPPC PPCPAPPVAG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW
            QEGNVFSCSV MHEALHNRFT QKSLSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS TYLNWYQQKP GKAPKLLIYT ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (heavy chain)
            QVQLVESGGG LVKPGGSLRL SCAASGFTFS NYYMSWVRQA PGKGLEWISY ISGRGSTIFY
            ADSVKGRITI SRDNAKNSLF LQMNSLRAED TAVYFCVKDR GGYSPYWGQG TLVTVSSAST
            KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPP VAGPSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
            CSVMHEALHN HYTQKSLSLS LGK
            (light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS TYLNWYQQKP GKAPKLLIYT ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H138-L215, H151-H207, H230-h223, H233-h226, H264-H324, H370-H428, h22-h96, h131-l215, h144-h200, h257-h317, h363-h421, L23-L88, L135-L195, l23-l88, l135-l195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of ovarian cancer
TARGET      CD3E [HSA:916] [KO:K06451]
            MUC16 (CA125) [HSA:94025] [KO:K16145]
  PATHWAY   hsa04660(916)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D12007  Ubamatamab (USAN)
               Other
                MUC16 (CA125)
                 D12007  Ubamatamab (USAN)
DBLINKS     CAS: 2305629-50-7
///
